{
      "ptx_code": "PTX185",
      "chem_name": "Rosiglitazone",
      "casrn": "122320-73-4",
      "dtxsid": "DTXSID7037131",
      "smiles": "CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=NC=CC=C1",
      "inchikey": "YASAKCUCGLMORW-UHFFFAOYSA-N",
      "label": "PTX185 | Rosiglitazone",
      "pubchem_cid": "77999",
      "drugbank_id": "DB00412",
      "use_class": "Pharmaceutical",
      "tox_class": "Hepatotoxicity; Cardiotoxicity",
      "formula": "C18H19N3O3S",
      "chem_name_user": "Rosiglitazone",
      "mw_g_mol": "357.43",
      "solubility_h2o_mol_liter": "2.50e-05",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "2.04e-09",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "7.08",
      "source_kaw": "LSER",
      "pka_acid": "6.09",
      "pka_base": "6.91",
      "source_pka": "UFZ; Sirius T3",
      "log_kow_liter_liter": "2.97",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "2.62",
      "source_dlipw": "Kow QSAR (\u2206mw = 1)",
      "freely_dissolved_fraction": "0.49",
      "density_kg_liter": "1.35",
      "source_density": "COMPTOX",
      "boiling_point": "",
      "source_boiling_point": "",
      "melting_point": "122.50",
      "source_melting_point": "CompTox (Jean-Claude Bradley Open Melting Point Dataset)",
      "vapor_pressure": "",
      "source_vapor_pressure": "",
      "baseline_drerio": "972.29",
      "baseline_dmagna": "468.92",
      "baseline_celegans": "1055.96",
      "baseline_xlaevis": "322.98",
      "baseline_dmelanogaster": "4190.40",
      "baseline_cells": "1.06e-04",
      "baseline_cells_generic_micromole_liter_free_ec10": "5.19e-05",
      "moa_drugbank": "Rosiglitazone acts as a highly selective and potent agonist at peroxisome proliferator activated receptors (PPAR) in target tissues for insulin action such as adipose tissue, skeletal muscle, and liver. Activation of PPAR-gamma receptors regulates the transcription of insulin-responsive genes involved in the control of glucose production, transport, and utilization. In this way, rosiglitazone enhances tissue sensitivity to insulin.",
      "protein_binding": "99.8% bound to plasma proteins, primarily albumin.",
      "moa_t3db": "",
      "aop": [],
      "targets": []
}